Bart Spiesschaert

Principal Scientist

‍Boehringer Ingelheim

Principal Scientist

‍Boehringer Ingelheim

#immunology #cancerbiology

#Europe

I’ve never been a traditional doctor in veterinary medicine. The bigger picture of general health improvement has always been my main interest.

Eric Smith

Director

‍Marker Therapeutics, Inc.

Director

‍Marker Therapeutics, Inc.

#cancerbiology #mammaliancellculture

#NorthAmerica

I have always been fond of puzzles from jigsaw to biological. There is nothing more satisfying than filling in the missing details to arrive at the big picture. When presented with tasks, goals, or pr

Giacomo Cavalli

Principal Investigator

‍Institute of Human Genetics

Principal Investigator

‍Institute of Human Genetics

#developmentalbiology #cancerbiology #epigenetics #genomics

#Europe

DNA is fundamental for life, but we are more than our DNA! In order to function, this molecule must be condensed in the cell nucleus, where it is contained.

Mark Cragg

Chair in Experimental Cancer biology

‍University of Southampton

Chair in Experimental Cancer biology

‍University of Southampton

#cancerbiology

#Europe

Mark Cragg is Professor of Experimental Cancer Biology in the School of Cancer Sciences at the University of Southampton Faculty of Medicine.

Natalie Grinshtein

Director, Cancer Target Discovery

‍Seagen

Director, Cancer Target Discovery

‍Seagen

#immunology #oncology #cancerbiology

#NorthAmerica

Scientific R&D leader in the field of targeted oncology and immunology with 7 years of industry experience and 20+ years in the oncology space
Expertise in target discovery and validation, cancer

Victoria Appleman

Principal Scientist

‍Takeda Oncology

Principal Scientist

‍Takeda Oncology

#cancerbiology #immunooncology

#NorthAmerica

Vicky Appleman has extensive experience in cancer biology and immuno-oncology, and is currently the discovery research lead for Takeda Oncology's STING agonist programs.